Companies / Industrials
FTV
Fortive
Industrial Machinery & Supplies & Components
Industrial Machinery & Supplies & ComponentsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health62
Growth20
Profitability65
Cash generation97
Balance sheet31
Dilution control95
Key ratios and five-year financials
Latest quarter revenue YoY (2026-10-02)7.8%Revenue growth (FY)1.9%Revenue CAGR (3y)-10.6%Gross margin63.5%Operating margin17.3%Net margin13.9%Free cash flow margin23.5%R&D / revenue6.2%Stock comp / revenue2.8%Net debt / operating cash flow3.44xCurrent ratio0.71Diluted share count change-5.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $5.3B | $5.8B | $3.9B | $4.1B | $4.2B |
| Gross profit | $3.0B | $3.4B | $2.5B | $2.6B | $2.6B |
| Operating income | $813M | $987M | $574M | $716M | $720M |
| Net income | $608M | $755M | $866M | $833M | $579M |
| Operating cash flow | $961M | $1.3B | $1.4B | $1.5B | $1.1B |
| Capital expenditure | $50M | $96M | $79M | $86M | $105M |
| Free cash flow | $911M | $1.2B | $1.3B | $1.4B | $978M |
| R&D | $355M | $402M | $237M | $251M | $259M |
| Stock-based comp | $77M | $94M | $94M | $90M | $117M |
| Buybacks | $0 | $443M | $273M | $890M | $1.6B |
| Dividends | $98M | $100M | $102M | $111M | $92M |
| Cash | $819M | $709M | $1.9B | $813M | $376M |
| Total debt | $6.1B | $4.3B | $3.6B | $4.1B | $4.1B |
| Equity | $9.5B | $9.7B | $10.3B | $10.2B | $6.5B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.